Pregabalin vs Gabapentin for Anxiety: Which Works Better?
- Dr. Kimryn Rathmell
- 3 days ago
- 7 min read
Introduction of Pregabalin vs Gabapentin for Anxiety
Pregabalin (brand name Lyrica) and Gabapentin (brand name Neurontin) are two of the most closely related medicines in psychiatry and neurology — and the question of which works better for anxiety is one that patients, prescribers, and researchers have been debating for years. They share the same binding target, the same drug class, and overlapping indications. Yet they differ in ways that matter clinically: their bioavailability, their speed of onset, their regulatory status for anxiety, and what the evidence actually shows.
This complete comparison guide covers how each medicine works, what the clinical trial evidence shows for anxiety, how they differ pharmacologically, their side effect profiles, and the practical question of which is the better choice depending on the type of anxiety and patient circumstances.
For authoritative clinical guidance on anxiety disorders and their pharmacological treatment, the NIH National Institute of Mental Health provides evidence-based information at: https://www.nimh.nih.gov/health/topics/anxiety-disorders
What Are They? The Essentials
Pregabalin (Lyrica)
Pregabalin is a gabapentinoid anticonvulsant developed specifically as a successor to Gabapentin with improved pharmacokinetic properties. In the USA, it is FDA-approved for: diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for partial-onset seizures. It is NOT FDA-approved in the USA for anxiety disorders — however, in Europe and the UK, Pregabalin is fully licensed for Generalised Anxiety Disorder (GAD) and is recommended as a first-line treatment in NICE guidelines. It is widely prescribed off-label for anxiety in the USA.
Gabapentin (Neurontin)
Gabapentin is the older gabapentinoid, originally developed as an anticonvulsant. It is FDA-approved for: postherpetic neuralgia and adjunctive therapy for partial seizures. Like Pregabalin, it is NOT FDA-approved for anxiety in the USA but is widely used off-label. It lacks the European regulatory approval for anxiety that Pregabalin holds.
At TheMedicineKart, we stock [Pregabalin 300mg] from WHO-GMP certified manufacturers. A valid prescription is required.
Same Mechanism — But Not the Same Medicine
Both Pregabalin and Gabapentin work through the same primary mechanism: they bind to the alpha-2-delta subunit of voltage-gated calcium channels in neurons, reducing calcium influx and thereby reducing the release of excitatory neurotransmitters including glutamate, noradrenaline, and substance P.
This mechanism reduces neuronal hyperexcitability — the state associated with anxiety, pain hypersensitivity, and seizure activity.
Where they diverge pharmacokinetically:
The critical difference between Pregabalin and Gabapentin is not their mechanism but their absorption:
Gabapentin
absorption is non-linear — it saturates the intestinal transport system at higher doses, meaning higher doses do not produce proportionally higher blood levels. Bioavailability falls from approximately 60% at 300mg doses to as low as 33% at 1,600mg doses. This makes dosing unpredictable at higher doses.
Pregabalin
absorption is linear across its full dose range — bioavailability is approximately 90% regardless of dose. This means higher doses reliably produce higher blood levels in a predictable, proportional way.
The practical result:
Pregabalin is more predictable, more reliably absorbed, and reaches effective blood levels faster than Gabapentin — which is reflected in the stronger clinical trial evidence for anxiety.
The FDA's prescribing information for both medicines is available at: https://www.fda.gov/drugs
What the Evidence Shows for Anxiety
Pregabalin for anxiety — stronger evidence base:
Pregabalin has been evaluated in multiple high-quality randomised controlled trials (RCTs) for Generalised Anxiety Disorder (GAD), Social Anxiety Disorder, and panic disorder:
Multiple Phase III RCTs demonstrated Pregabalin at 150–600mg/day significantly reduces HAM-A (Hamilton Anxiety Rating Scale) scores compared to placebo in GAD
Onset of anxiolytic effect as early as Week 1 — faster than SSRIs and SNRIs which typically take 2–4 weeks
Effect size for GAD is comparable to benzodiazepines and SNRIs
European Medicines Agency (EMA) approved Pregabalin for GAD based on this evidence base
NICE (UK) guidelines list Pregabalin as a first-line treatment option for GAD alongside SSRIs
Gabapentin for anxiety — more limited evidence:
Gabapentin's evidence base for anxiety is significantly thinner than Pregabalin's:
Smaller trials and case series suggest benefit in social anxiety disorder and performance anxiety
One RCT showed benefit in social phobia at 900–3,600mg/day
No large Phase III RCTs for GAD comparable to those completed for Pregabalin
Not licensed for anxiety anywhere in the world
The bottom line: Pregabalin has substantially stronger clinical evidence for anxiety, particularly for GAD, than Gabapentin.
The NIH provides a comprehensive review of gabapentinoid mechanisms and clinical evidence at: https://www.ncbi.nlm.nih.gov/books/NBK470455/
Head-to-Head Comparison Table
Feature | Pregabalin (Lyrica) | Gabapentin (Neurontin) |
Drug Class | Gabapentinoid | Gabapentinoid |
Mechanism | Alpha-2-delta calcium channel binding | Alpha-2-delta calcium channel binding |
Bioavailability | ~90% (linear, predictable) | 33–60% (non-linear, falls at higher doses) |
Onset of Anxiolytic Effect | ~1 week | ~1–2 weeks |
Licensed for Anxiety (Europe/UK) | ✓ Yes — GAD (NICE first-line) | ✗ No |
FDA-Approved for Anxiety (USA) | ✗ No (off-label) | ✗ No (off-label) |
FDA-Approved Indications | Neuropathy, fibromyalgia, seizures | Neuropathy, seizures |
RCT Evidence for GAD | Strong — multiple Phase III trials | Limited — small studies only |
Standard Anxiety Dose | 150–300 mg/day in 2–3 divided doses | 900–3,600 mg/day in 3 divided doses |
Tablet/Capsule Strengths | 75 mg, 150 mg, 300 mg | 100 mg, 300 mg, 400 mg, 600 mg, 800 mg |
Schedule (USA) | Schedule V | Not scheduled federally (some states vary) |
Available at TheMedicineKart | ✓ 300 mg | ✗ |
Dependency Risk | Moderate — taper on stopping | Moderate — taper on stopping |
Approved and Off-Label Indications Compared
Tick Species | Main Disease Risk | Primary Geographic Range |
Black-legged tick (Ixodes scapularis) — deer tick | Lyme disease, Anaplasmosis, Babesiosis | Northeast, Midwest, expanding south |
Western black-legged tick (Ixodes pacificus) | Lyme disease | Pacific coast |
American dog tick (Dermacentor variabilis) | Rocky Mountain spotted fever, Tularemia | Widespread across USA |
Lone star tick (Amblyomma americanum) | Ehrlichiosis, STARI, Alpha-gal syndrome | Southeast, expanding north |
Rocky Mountain wood tick (Dermacentor andersoni) | Rocky Mountain spotted fever, Colorado tick fever | Rocky Mountain states |
Side Effect Profiles — Where They Overlap and Differ
Shared side effects (both medicines):
Dizziness and somnolence (sedation) — most common, dose-dependent
Weight gain — through appetite stimulation and fluid retention
Peripheral oedema (ankle swelling)
Cognitive blurring — difficulty with concentration and memory ("brain fog")
Dependency and withdrawal syndrome — both require gradual tapering after prolonged use, not abrupt stopping
Rebound anxiety on abrupt withdrawal
Where Pregabalin tends to produce more prominent effects:
Euphoria at higher doses — which contributes to its Schedule V classification and abuse potential
More pronounced weight gain in some patients
Slightly stronger sedation at equivalent doses
Where Gabapentin may be somewhat better tolerated:
Lower Schedule status — not federally scheduled (though some states have restricted it)
Some patients report less pronounced euphoria and lower subjective dependency concerns
More gradual dose titration possible due to multiple available strengths
Critical warning for both medicines:
Never stop either Pregabalin or Gabapentin abruptly after prolonged use. Both can cause a withdrawal syndrome including rebound anxiety, insomnia, sweating, nausea, and in severe cases seizures. Always taper under medical supervision.
Which Should You Choose?
Pregabalin is the stronger choice for anxiety if:
You have Generalised Anxiety Disorder — it has the most robust evidence base and European regulatory approval for this specific indication
You need faster onset — anxiolytic effect can begin within 1 week vs SSRIs which take 2–4 weeks
You also have comorbid neuropathic pain or fibromyalgia — Pregabalin covers both simultaneously
Predictable, linear dosing is important to your prescriber
You have tried SSRIs/SNRIs and not achieved adequate response
Gabapentin may be considered if:
Pregabalin is not available or not tolerated
You have social anxiety or performance anxiety specifically — Gabapentin has some evidence here
Your prescriber prefers a non-scheduled medicine (varies by state)
Comorbid restless legs syndrome is present — Gabapentin ER (Horizant) is FDA-approved for this
Neither should be first-line for anxiety if:
SSRIs (sertraline, escitalopram) or SNRIs (venlafaxine, duloxetine) have not been tried first — these remain the first-line evidence-based pharmacological treatments for most anxiety disorders per international guidelines. Pregabalin and Gabapentin are typically used as second-line options or in patients where SSRIs are not tolerated.
For our complete guide to Generalised Anxiety Disorder including all treatment options: [Generalised Anxiety Disorder: Symptoms, Causes and Treatment]
For fibromyalgia — where Pregabalin is FDA-approved and highly relevant: [Fibromyalgia: Symptoms, Causes and Treatment Guide]
Frequently Asked Questions
Is Pregabalin the same as Gabapentin?
No. They are both gabapentinoids that share the same alpha-2-delta calcium channel binding mechanism, but Pregabalin has approximately 90 percent linear bioavailability compared to Gabapentin's variable 33 to 60 percent. Pregabalin is more predictably absorbed, has stronger clinical trial evidence for anxiety, and holds European regulatory approval for GAD — which Gabapentin does not.
How quickly does Pregabalin work for anxiety?
Clinical trials show Pregabalin produces measurable anxiolytic effects within one week of starting treatment — significantly faster than SSRIs and SNRIs which typically take 2 to 4 weeks. Full benefit continues to develop over 4 to 6 weeks. This faster onset is one of the key clinical advantages of Pregabalin for anxiety.
Can Pregabalin be used long-term for anxiety?
Pregabalin can be used longer-term for anxiety, and clinical trials have demonstrated maintained efficacy for up to 6 months. However, the risk of dependency and withdrawal syndrome increases with prolonged use. Long-term use should be regularly reviewed by your prescriber, and discontinuation requires gradual tapering rather than abrupt stopping.
Is Pregabalin addictive?
Pregabalin has a Schedule V classification in the USA, reflecting a recognised potential for abuse and dependency — particularly at higher doses where euphoric effects can occur. Physical dependency can develop with prolonged use, requiring tapering on discontinuation. It is not appropriate for patients with a history of substance use disorder without careful psychiatric evaluation.
What dose of Pregabalin is used for anxiety?
The typical starting dose for anxiety is 75mg twice daily (150mg total per day), which can be increased to 150mg twice daily (300mg total) or 200mg three times daily (600mg total) depending on response and tolerability. The dose range in GAD clinical trials was 150 to 600mg per day. Your prescriber will determine the appropriate starting dose and titration schedule for your specific situation.
Comments